Ignatov T - Search Results

1

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.

Ignatov A, Ignatov T, Weissenborn C, Eggemann H, Bischoff J, Semczuk A, Roessner A, Costa SD, Kalinski T. Ignatov A, et al. Among authors: ignatov t. Breast Cancer Res Treat. 2011 Jul;128(2):457-66. doi: 10.1007/s10549-011-1584-1. Epub 2011 May 24. Breast Cancer Res Treat. 2011. PMID: 21607586

2

BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.

Ignatov T, Poehlmann A, Ignatov A, Schinlauer A, Costa SD, Roessner A, Kalinski T, Bischoff J. Ignatov T, et al. Among authors: ignatov a. Breast Cancer Res Treat. 2013 Sep;141(2):205-12. doi: 10.1007/s10549-013-2693-9. Epub 2013 Sep 13. Breast Cancer Res Treat. 2013. PMID: 24026861

3

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

Ignatov T, Eggemann H, Costa SD, Roessner A, Kalinski T, Ignatov A. Ignatov T, et al. Among authors: ignatov a. J Cancer Res Clin Oncol. 2014 Sep;140(9):1457-63. doi: 10.1007/s00432-014-1704-5. Epub 2014 May 14. J Cancer Res Clin Oncol. 2014. PMID: 24825122

4

Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients.

Eggemann H, Ehricke J, Ignatov T, Fettke F, Semczuk A, Costa SD, Ignatov A. Eggemann H, et al. Among authors: ignatov t, ignatov a. Cancer Invest. 2015 May;33(5):193-6. doi: 10.3109/07357907.2015.1020384. Epub 2015 Apr 1. Cancer Invest. 2015. PMID: 25831456

5

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells.

Ignatov A, Ignatov T, Roessner A, Costa SD, Kalinski T. Ignatov A, et al. Among authors: ignatov t. Breast Cancer Res Treat. 2010 Aug;123(1):87-96. doi: 10.1007/s10549-009-0624-6. Epub 2009 Nov 13. Breast Cancer Res Treat. 2010. PMID: 19911269

6

Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.

Ignatov T, Eggemann H, Semczuk A, Smith B, Bischoff J, Roessner A, Costa SD, Kalinski T, Ignatov A. Ignatov T, et al. Among authors: ignatov a. Am J Obstet Gynecol. 2010 Dec;203(6):595.e9-16. doi: 10.1016/j.ajog.2010.07.034. Epub 2010 Oct 20. Am J Obstet Gynecol. 2010. PMID: 20965484

7

GPER-1 expression decreases during breast cancer tumorigenesis.

Ignatov T, Weißenborn C, Poehlmann A, Lemke A, Semczuk A, Roessner A, Costa SD, Kalinski T, Ignatov A. Ignatov T, et al. Among authors: ignatov a. Cancer Invest. 2013 Jun;31(5):309-15. doi: 10.3109/07357907.2013.789901. Cancer Invest. 2013. PMID: 23688258

8

Ultrasonography-guided breast-conserving surgery is superior to palpation-guided surgery for palpable breast cancer.

Eggemann H, Ignatov T, Beni A, Costa SD, Ignatov A. Eggemann H, et al. Among authors: ignatov t, ignatov a. Clin Breast Cancer. 2014 Feb;14(1):40-5. doi: 10.1016/j.clbc.2013.08.016. Epub 2013 Oct 26. Clin Breast Cancer. 2014. PMID: 24169374

9

GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.

Weißenborn C, Ignatov T, Poehlmann A, Wege AK, Costa SD, Zenclussen AC, Ignatov A. Weißenborn C, et al. Among authors: ignatov t, ignatov a. J Cancer Res Clin Oncol. 2014 Apr;140(4):663-71. doi: 10.1007/s00432-014-1598-2. Epub 2014 Feb 11. J Cancer Res Clin Oncol. 2014. PMID: 24515910

10

GPER functions as a tumor suppressor in triple-negative breast cancer cells.

Weißenborn C, Ignatov T, Ochel HJ, Costa SD, Zenclussen AC, Ignatova Z, Ignatov A. Weißenborn C, et al. Among authors: ignatov t, ignatov a. J Cancer Res Clin Oncol. 2014 May;140(5):713-23. doi: 10.1007/s00432-014-1620-8. Epub 2014 Feb 20. J Cancer Res Clin Oncol. 2014. PMID: 24553912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page